AmanSaraf

MASTEK looks good Positionally

Long
NSE:MASTEK   MASTEK
Chart Structure:
- Stock is in a continuous uptrend since May.
- Currently, the price is near the All-time High Range (It might close at ATH)
- Price is around 2793.45 at the time of the study.

Volume & Deliveries:
- Huge accumulation has been seen in the second half of July.
- Around 9.48 lac shares were delivered during the period with an average delivery of 1.58 lac shares/day whereas the average deliveries prior was 53,000 shares/day.
- Above-average deliveries are being seen in the first half of August.
- On 1st September around 1.88 lac shares were delivered (around 5x of current average)
- 3 Mutual Funds bought the Significant Quantity of shares in July whereas 5 MFs reduced small quantities of MASTEK in their portfolio.

Relative Strength:
- MASTEK is Relatively stronger than Nifty50 as well as the Midcap index.
- It has outperformed the Nifty50 & its Sector (Nifty-IT) in 1W, 1M, 3M, 6M, 1Y, 2Y & 5Y timeframes.
- Historical chart data shows that Mastek has performed well when it became RS positive and gave significant returns while outperforming the Markets.
- After becoming RS positive in April (with the new ARS date) RS has improved significantly and not flipped flopped.
- While Nifty & Midcap corrected, MASTEK has shown little correction.
- Spread Chart breakout has been observed 3 sessions back.

Financial Performance:
- Q1 sales growth stood at 7% QoQ & 34% YoY
- Q1 PBT growth stood at 9% QoQ & 49% YoY
- Q1 PAT growth stood at 13% QoQ & 73% YoY
- Overall financials have improved.

Sectoral Performance:

- Since its breakout on 15th July, Nifty IT has grown by 17.5%
- The sector is consistently outperforming Nifty50 significantly.
- MASTEK has outperformed Nifty-IT on 1W, 3M, 6M & 1Y timeframes.

TLDR (Too Long Didn't Read):
- Stock is near ATH
- Stock has good volume & deliveries
- Stock's RS is strong, outperforming Nifty & Sector.
- Co.'s financial performance was good in Q1.

A good Stock to Study & keep eyes upon.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.